This information collection request is approved as amended by FDA. OMB notes that FDA will forward final versions of the instruments associated with Phase I of the study and will consult with OMB before administering Phase II to determine whether and how this information collection request should be amended to incorporate any changes to the instruments, methodology and/or the language being tested.
Inventory as of this Action
Requested
Previously Approved
10/31/2010
36 Months From Approved
1,200
0
0
705
0
0
0
0
0
Study of users and potential users of male latex condoms to evaluate the understandability of the condom labeling language proposed in a draft guidance as well as future revised version of the labeling.
US Code:
21 USC 393
Name of Law: Medical Device Admendment
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.